Runben Biotechnology Co., Ltd. (SHA:603193)
China
· Delayed Price · Currency is CNY 22.37
-0.18 (-0.80%)
At close: Mar 9, 2026
Runben Biotechnology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Operating Revenue | 1,517 | 1,317 | 1,032 | 855.65 | 581.91 | 442.66 | Upgrade
|
| Other Revenue | 0.77 | 0.77 | 0.66 | 0.44 | 0.24 | 0.17 | Upgrade
|
| Revenue | 1,518 | 1,318 | 1,033 | 856.09 | 582.15 | 442.83 | Upgrade
|
| Revenue Growth (YoY) | 21.75% | 27.61% | 20.66% | 47.06% | 31.46% | 58.93% | Upgrade
|
| Cost of Revenue | 637.28 | 553.2 | 453.34 | 393.28 | 275.75 | 210.99 | Upgrade
|
| Gross Profit | 880.9 | 764.98 | 579.62 | 462.81 | 306.4 | 231.83 | Upgrade
|
| Selling, General & Admin | 502.36 | 411.86 | 301.68 | 257.21 | 155.39 | 109.8 | Upgrade
|
| Research & Development | 35.59 | 35.07 | 25.69 | 19.51 | 13.6 | 10.71 | Upgrade
|
| Other Operating Expenses | 10.11 | 9.39 | 9.42 | 8.77 | 6.83 | 4.46 | Upgrade
|
| Operating Expenses | 548.91 | 456.79 | 336.99 | 285.47 | 175.82 | 125 | Upgrade
|
| Operating Income | 331.99 | 308.19 | 242.62 | 177.34 | 130.58 | 106.84 | Upgrade
|
| Interest Expense | -0.09 | -0.13 | -0.26 | -0.43 | -0.54 | - | Upgrade
|
| Interest & Investment Income | 24.72 | 34.84 | 16.4 | 7.18 | 6.09 | 0.8 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | 0.24 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -5.29 | -0.13 | -0.05 | -0.16 | -0.05 | -0.03 | Upgrade
|
| EBT Excluding Unusual Items | 351.33 | 342.76 | 258.72 | 183.94 | 136.32 | 107.61 | Upgrade
|
| Gain (Loss) on Sale of Investments | 3.99 | 3.59 | - | - | - | 0.36 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.28 | -0.6 | 0.07 | 0.05 | 0 | - | Upgrade
|
| Asset Writedown | 0.74 | - | - | - | - | - | Upgrade
|
| Other Unusual Items | 6.25 | 6.25 | 9.13 | 4.29 | 5.31 | 2.28 | Upgrade
|
| Pretax Income | 362.03 | 352 | 267.93 | 188.27 | 141.63 | 110.24 | Upgrade
|
| Income Tax Expense | 56.71 | 51.84 | 41.9 | 28.23 | 20.98 | 15.53 | Upgrade
|
| Net Income | 305.33 | 300.16 | 226.03 | 160.04 | 120.65 | 94.71 | Upgrade
|
| Net Income to Common | 305.33 | 300.16 | 226.03 | 160.04 | 120.65 | 94.71 | Upgrade
|
| Net Income Growth | -0.28% | 32.80% | 41.23% | 32.66% | 27.38% | 165.51% | Upgrade
|
| Shares Outstanding (Basic) | 402 | 406 | 353 | 341 | 335 | 306 | Upgrade
|
| Shares Outstanding (Diluted) | 402 | 406 | 353 | 341 | 335 | 306 | Upgrade
|
| Shares Change (YoY) | -0.22% | 14.85% | 3.71% | 1.61% | 9.69% | 499.54% | Upgrade
|
| EPS (Basic) | 0.76 | 0.74 | 0.64 | 0.47 | 0.36 | 0.31 | Upgrade
|
| EPS (Diluted) | 0.76 | 0.74 | 0.64 | 0.47 | 0.36 | 0.31 | Upgrade
|
| EPS Growth | -0.05% | 15.63% | 36.17% | 30.56% | 16.13% | -55.71% | Upgrade
|
| Free Cash Flow | 194.68 | 183.02 | 238.87 | 124.67 | -13.38 | 28.93 | Upgrade
|
| Free Cash Flow Per Share | 0.48 | 0.45 | 0.68 | 0.37 | -0.04 | 0.10 | Upgrade
|
| Dividend Per Share | 0.430 | 0.410 | 0.170 | - | - | - | Upgrade
|
| Dividend Growth | 22.86% | 141.18% | - | - | - | - | Upgrade
|
| Gross Margin | 58.02% | 58.03% | 56.11% | 54.06% | 52.63% | 52.35% | Upgrade
|
| Operating Margin | 21.87% | 23.38% | 23.49% | 20.71% | 22.43% | 24.13% | Upgrade
|
| Profit Margin | 20.11% | 22.77% | 21.88% | 18.70% | 20.72% | 21.39% | Upgrade
|
| Free Cash Flow Margin | 12.82% | 13.88% | 23.13% | 14.56% | -2.30% | 6.53% | Upgrade
|
| EBITDA | 351.44 | 327.81 | 262.46 | 194.59 | 138.59 | 114.84 | Upgrade
|
| EBITDA Margin | 23.15% | 24.87% | 25.41% | 22.73% | 23.81% | 25.93% | Upgrade
|
| D&A For EBITDA | 19.46 | 19.62 | 19.84 | 17.25 | 8.01 | 8.01 | Upgrade
|
| EBIT | 331.99 | 308.19 | 242.62 | 177.34 | 130.58 | 106.84 | Upgrade
|
| EBIT Margin | 21.87% | 23.38% | 23.49% | 20.71% | 22.43% | 24.13% | Upgrade
|
| Effective Tax Rate | 15.66% | 14.73% | 15.64% | 14.99% | 14.82% | 14.09% | Upgrade
|
| Revenue as Reported | 1,518 | 1,318 | 1,033 | 856.09 | 582.15 | 442.83 | Upgrade
|
| Advertising Expenses | - | 320.61 | 218.47 | 187.47 | 107.9 | 77.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.